Donor-derived CAR-T Cells in the Treatment of AML Patients
Condition: AML Intervention: Drug: CAR-T cells Sponsor: Beijing Immunochina Medical Science& Technology Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2021 Category: Research Source Type: clinical trials